Last quarter (Q4 2023), Denali Therapeutics's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q4, Denali Therapeutics's net income was $-119.47M. See Denali Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 329.26M	$ 330.53M	$ 108.46M	$ 48.66M	$ 335.66M	$ 26.68M
Cost of Revenue	-	-	-	-	-	-
Gross Profit	$ 329.26M	$ 330.53M	$ 108.46M	-	-	-
Operating Expense	$ 100.26M	$ 527.23M	$ 449.21M	$ 344.41M	$ 272.94M	$ 239.86M
Operating Income	$ 229.01M	$ -196.70M	$ -340.74M	$ -295.75M	$ 62.72M	$ -213.18M
Net Non Operating Interest Income Expense	$ 11.03M	-	-	$ 4.59M	$ 9.24M	$ 15.22M
Other Income Expense	$ -26.03M	$ -51.51M	$ -18.17M	-	-	-
Pretax Income	$ 266.07M	$ -145.19M	$ -325.97M	$ -291.16M	$ 71.96M	$ -197.97M
Tax Provision	$ 30.00K	$ 30.00K	$ 21.00K	$ -575.00K	$ 823.00K	$ -351.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ 266.04M	$ -145.22M	$ -325.99M	$ -290.58M	$ 71.14M	$ -197.61M
Basic EPS	$ -0.32	$ -1.06	$ -2.60	$ -2.39	$ 0.65	$ -2.07
Diluted EPS	$ -0.39	$ -1.06	$ -2.60	$ -2.39	$ 0.63	$ -2.07
Basic Average Shares	$ 411.84M	$ 137.37M	$ 125.53M	$ 121.52M	$ 108.97M	$ 95.61M
Diluted Average Shares	$ 411.84M	$ 137.37M	$ 125.53M	$ 121.52M	$ 112.70M	$ 95.61M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 100.26M	$ 527.23M	$ 449.21M	$ 344.41M	$ 272.94M	$ 239.86M
Net Income From Continuing And Discontinued Operation	$ -45.87M	$ -145.22M	$ -325.99M	$ -290.58M	$ 71.14M	$ -197.61M
Normalized Income	$ 50.51M	$ -114.70M	$ -257.52M	$ -290.58M	$ 71.14M	$ -197.61M
Interest Expense	-	-	-	-	-	-
EBIT	$ 266.07M	$ -145.19M	$ -325.97M	$ -295.75M	$ 62.72M	$ -213.18M
EBITDA	$ 280.55M	$ -128.49M	$ -315.57M	$ -287.16M	$ 71.25M	$ -205.19M

Currency in USD

Denali Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing